In this study, we confirmed that MBNL1 can increase the expression of Myocardin by inhibiting the degradation of Myocardin mRNA, which implicate myocardial hypertrophy and its subsequent pathophysiology. Here, MYOCD is linked to cardiac hypertrophy.